How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?

How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?

Bibliographic Details
Main Authors: Doan Luong Hien, Brandon Huy Pham, Quan Dong Nguyen
Format: Article
Language:English
Published: Knowledge E 2020-10-01
Series:Journal of Ophthalmic & Vision Research
Online Access:https://doi.org/10.18502/jovr.v15i4.7777
id doaj-e3f739e4dfc045f39746d02760532f23
record_format Article
spelling doaj-e3f739e4dfc045f39746d02760532f232020-11-25T04:01:44ZengKnowledge EJournal of Ophthalmic & Vision Research2008-322X2020-10-011544244510.18502/jovr.v15i4.7777How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?Doan Luong Hien0Brandon Huy Pham1Quan Dong Nguyen2 Pham Ngoc Thach University of Medicine, Saigon, Vietnam Pham Ngoc Thach University of Medicine, Saigon, Vietnam Pham Ngoc Thach University of Medicine, Saigon, Vietnamhttps://doi.org/10.18502/jovr.v15i4.7777
collection DOAJ
language English
format Article
sources DOAJ
author Doan Luong Hien
Brandon Huy Pham
Quan Dong Nguyen
spellingShingle Doan Luong Hien
Brandon Huy Pham
Quan Dong Nguyen
How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
Journal of Ophthalmic & Vision Research
author_facet Doan Luong Hien
Brandon Huy Pham
Quan Dong Nguyen
author_sort Doan Luong Hien
title How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
title_short How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
title_full How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
title_fullStr How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
title_full_unstemmed How Do We Manage HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy?
title_sort how do we manage hla-b27-associated ocular inflammation refractory or intolerant to conventional immunomodulatory therapy?
publisher Knowledge E
series Journal of Ophthalmic & Vision Research
issn 2008-322X
publishDate 2020-10-01
url https://doi.org/10.18502/jovr.v15i4.7777
work_keys_str_mv AT doanluonghien howdowemanagehlab27associatedocularinflammationrefractoryorintoleranttoconventionalimmunomodulatorytherapy
AT brandonhuypham howdowemanagehlab27associatedocularinflammationrefractoryorintoleranttoconventionalimmunomodulatorytherapy
AT quandongnguyen howdowemanagehlab27associatedocularinflammationrefractoryorintoleranttoconventionalimmunomodulatorytherapy
_version_ 1724445396551335936

Similar Items